Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
1.
Oman Medical Journal. 2013; 28 (6): 441-444
em Inglês | IMEMR | ID: emr-142966

RESUMO

Solid pseudopapillary neoplasm of the pancreas is a rare tumor of the pancreas often detected initially on imaging. Of uncertain histogenesis, it has a low-grade malignant potential with excellent post-surgical curative rates and rare metastasis. Despite advances in imaging, pseudocysts and other cystic neoplasms feature in the differential diagnosis. Pathological and/or cytological evaluation remains the gold standard in reaching a definitive diagnosis. On morphology alone, other primary pancreatic tumors and metastatic tumors pose a diagnostic challenge. Recent advances in immunohistochemical characterization have made the histopathologic diagnosis more specific and, in turn, shed light on the likely histogenesis of this rare tumor. We report a case of solid pseudopapillary neoplasm of the pancreas that was suspected on radiology and diagnosed intraoperatively on imprint cytology guiding definitive surgery. The diagnostic dilemmas are reviewed.


Assuntos
Humanos , Feminino , Neoplasias Pancreáticas/diagnóstico , Diagnóstico Diferencial , Neoplasias das Glândulas Endócrinas , Literatura de Revisão como Assunto , Metástase Neoplásica , Radiologia , beta Catenina , Caderinas
2.
SQUMJ-Sultan Qaboos University Medical Journal. 2013; 13 (2): 202-217
em Inglês | IMEMR | ID: emr-126022

RESUMO

A series of phase II and randomised phase III trials in Asia and Europe have confirmed recently that advanced stage non-small-cell lung carcinoma patients with adenocarcinoma subtypes harbouring specific mutations when subjected to targeted therapy experience equivalent survival outcomes as those treated with chemotherapy and are spared from its side effects. The concept of chemotherapy for all is fading, and therapy optimisation has emerged as a paradigm shift in treatment. This article briefly describes cellular mechanisms involved in lung carcinogenesis which provide a molecular basis for targeted therapy. Advances in molecular biology have improved our understanding of mechanisms involved in primary or secondary drug resistance. Evolving biomarkers of prognostic and predictive importance, and the impact of translational research on outcomes are also covered. A marker is considered prognostic if it predicts the outcome, regardless of the treatment, and predictive if it predicts the outcome of a specific therapy


Assuntos
Humanos , Neoplasias Pulmonares , Metástase Neoplásica , Antineoplásicos , Biomarcadores , Resultado do Tratamento , Fator de Crescimento Epidérmico , Fatores de Crescimento do Endotélio Vascular , Inibidores de Proteínas Quinases , Anticorpos Monoclonais Humanizados
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA